Sharing Clinical Trial Reports and Data Access – Some practicalities Merete Jørgensen 26 May 2014 DSBS Hillerød.

Slides:



Advertisements
Similar presentations
Presentation of BE data in a product dossier Drs. Jan Welink Training workshop: Training of BE assessors, Kiev, October 2009.
Advertisements

Participation Requirements for a Guideline Panel Co-Chair.
Participation Requirements for a Patient Representative.
Research and Innovation Summary of MS questions on the Commission's proposal for DG Research & Innovation Research and Innovation Rules for Participation.
Role of Pharmaceutical Statistician March 10, 2009 The Role of the Pharmaceutical Statistician What can be improved? Per Larsson Head of Biostatistics.
The Innovative Medicines Initiative (IMI) The IMI Call and Evaluation Process Eva Lindgren.
Author Instructions How to upload a full session proposal with abstracts – two step process.
Sustainable Energy Systems Overview of contractual obligations, procedures and practical matters KICK-OFF MEETING.
Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.
Disclosing Freedom of Information Releases Ann Apps MIMAS, The University of Manchester, UK.
Front Matter Transmittal Letter Front Cover Title Page Forward or Preface Abstract Table of Contents List of Illustrations List of Abbreviations and Symbols.
Research Proposal Development of research question
Knowledge Update Clinical documentation: from preclinical studies to drug registration Split, 12 September 2008.
NCI Clinical Trials Reporting Program CTRP User Meeting May 2, 2012 Gene Kraus CTRP Program Director.
3 Dec 2003Market Operations Standing Committee1 Market Rule and Change Management Consultation Process John MacKenzie / Darren Finkbeiner / Ella Kokotsis,
Culture Programme - Selection procedure Katharina Riediger Infoday Praha 10/06/2010.
EMPRICAL RESEARCH REPORTS
IMSS005 Computer Science Seminar
ICH V1 An FDA Update Min Chen, M.S., RPh Office of Drug Safety Center for Drug Evaluation and Research FDA January 21, 2003.
Systematic Reviews.
Development of metadata in the National Statistical Institute of Spain Work Session on Statistical Metadata Genève, 6-8 May-2013 Ana Isabel Sánchez-Luengo.
Cost Policy Training Sponsored Project Training Program April 30, 2012 Beverly Blakeney & Jennifer Gagnon April 30, 2012Sponsored Project Training Program1.
Institutional Review Board for Human Subject Research: Does Your Research Need One? Merle Rosenzweig Michael Unsworth.
Name of Presentation Your name Faculty Sponsor: IRB Approval # Dates of IRB trainings (initial and Continuing ed)
0 eCPIC User Training: Resource Library These training materials are owned by the Federal Government. They can be used or modified only by FESCOM member.
SMARTFORM 3.0 January, 2012 Overview of Major Changes.
Insert your Small Grant Scheme Project Title Date: 4 th September, 2012 Exceptional healthcare, personally delivered Presented by.
An agency of the European Union Presented by: Emer Cooke and Truus Janse-de Hoog Update on Transparency Progress report from HMA/EMA TF on Transparency.
How to Submit An Amendment Tips from the 21 st CCLC Unit Updated September 17, 2009.
How to write a scientific article Nikolaos P. Polyzos M.D. PhD.
FY 2011 Budget Period Progress Report Cheri Daly
How To Design a Clinical Trial
How to Start An Industry Sponsored Clinical Trial
How to Log your Non-Profit Board Participation. Logging Board Participation Hours There area two steps to recording your Board Participation hours. 1.Add.
Research Methods Technical Writing Thesis Conference/Journal Papers
Data sharing: one pharmaceutical company’s approach and the statistical challenges envisaged Sara Hughes VP & Head, Statistics, Programming & Data Strategy,
“EMA policy on publication of Clinical Data” 27/11/2014SFdS - Journée Annuelle du groupe Biopharmacie & Santé.
DG Justice and Consumers Project Modifications DG Justice and Consumers.
Research Methods: 1 M.Sc. Physiotherapy/Podiatry/Pain Writing for Publication.
GCP (GOOD CLINICAL PRACTISE)
Halifax, 31 Oct – 3 Nov 2011ICT Accessibility For All Dirk Weiler Chairman of the ETSI IPR Special Committee Document No: GSC16-IPR-02 Source: ETSI Contact:
1 ClinicalTrials.gov PL Implementation Nick Ide Chief Architect, ClinicalTrials.gov National Library of Medicine (Contractor) May 12, 2008.
An agency of the European Union Guidance on the anonymisation of clinical reports for the purpose of publication in accordance with policy 0070 Industry.
ClinicalTrials.gov Requirements
How To Design a Clinical Trial
De-Identification Standards for CDISC Data Models
Clinicaltrials.gov Update
CTD Content Management
Investigator of Record – Definition
<Student’s name>
Support- IRDiRC Proposed Work Plan And Communication Strategy
Industry stakeholder follow-up meeting, 23 June 2015 Agenda topic 5
Approaches to Implementing CPT in Your Organization
Name of Small Business location
Claire McKinley, PMP, CCRP
Providing Access To Patient Level Clinical Trial Data
Disclosing Freedom of Information Releases
Understanding the Planned Changes to the Federal Policy on Protection of Human Subjects (the Common Rule) Megan Kasimatis Singleton, JD, MBE, CIP Assistant.
implementing NEW NIH Human subjects guidance
Investigator of Record – Definition
Investigator of Record – Definition
Approaches to Implementing in Your Organization
Insert your Springboard Project Title
Class Project Guidelines
Dr. N. S. Harding Chemical Engineering 477 March 8, 2018
High level working group on statistical confidentiality
Changes to the Common Rule and Single IRB (sIRB)
EUnetHTA Assembly May 2018.
Research with Human Subjects
Natasa Rajicic, ScD July 31, 2019
Presentation transcript:

Sharing Clinical Trial Reports and Data Access – Some practicalities Merete Jørgensen 26 May 2014 DSBS Hillerød

Data Sharing and Management Snafu in 3 Short Acts Sharing Clinical Trial Reports and Data Access26 May

Data Sharing commitment Access to results summaries Sharing results with trial participants Certifying commitment publicly Commitment to publish results EFPIA & PhRMA Joint Principles – 1 Jan May 2014Sharing Clinical Trial Reports and Data Access 3

Publicly available information from trials - before 1 March 2014 Scientific journalNovoNordisk-Trials.comClinicalTrials.gov Sharing Clinical Trial Reports and Data Access26 May

Our new Code-of-Conduct from 1 March 2014 Sharing Clinical Trial Reports and Data Access26 May 2014 Clinical Study Reports (CSRs) for trials completed after 1 January 2006 will be made available via Publishing clinical study reports CSRs for indications approved in US and EU will be published without appendices and will be redacted to remove patient and site- identifiable information. Access will be Governed by Independent Review Board (IRB) Based on research proposals, pre-defined protocols and statistical analyses plans Subject to publication rules and agreement to respect private and commercial confidentiality Novo Nordisk will grant researcher access to anonymised patient-level data from trials completed after Granting access to patient-level data 5

Availability of Clinical Reports - To Consider Sharing Clinical Trial Reports and Data Access Scope of Reports – when and how much 26 May 2014 Redaction principles Software to use for redaction Detailed proccesses and approvals To be made available – from where 6

CTR vs. redacted public CTR CTR structure (ICH E3): Sec. 1: Title page Sec. 2: Synopsis (separate document) Sec. 3-12: Report text (data- independent and data dependent) Sec. 13: Discussion and overall conclusions Sec. 14: End-of-text material (statistical tables (analyses and summaries), figures and listings); individual patient narratives Sec. 15: References App – Trial background App – Patient listings App – Completed CRFs App – Raw data listings Public CTR: Sec. 1: Include Sec. 2: Include – with appropriate redaction for PPD Sec. 3-12: Include – with appropriate redaction for PPD and CCI Sec. 13: Include Sec. 14: Include – except listings with individual data, individual subject profiles (e.g. PK) and individual narratives Sec. 15: Include !App – Exclude !App – Exclude !App – Exclude !App – Exclude Sharing Clinical Trial Reports and Data Access26 May

Personal identifiers (names, ids) Company Confidential Information Site ids Dates Verbatim text related to individuals All Narratives Never more than 2 indirect identifiers for an individual Redaction principles 26 May 2014Sharing Clinical Trial Reports and Data Access Slide no 8

Redaction Tools Sharing Clinical Trial Reports and Data Access26 May

Apply redaction Sharing Clinical Trial Reports and Data Access26 May

Apply redaction based on search pattern Sharing Clinical Trial Reports and Data Access26 May

Update of NovoNordisk-trials.com 26 May 2014Sharing Clinical Trial Reports and Data Access 12

26 May 2014 Add information on the trials for which CSRs are available Sharing Clinical Trial Reports and Data Access 13

For this initial period the CSRs that is made available will be listed on this page The list will be updated regularly A more sustainable solution will be implemented Design of information on CSRs available 26 May 2014 New text added List updated ‘monthly’ Sharing Clinical Trial Reports and Data Access 14

Finding the redacted reports 26 May 2014Sharing Clinical Trial Reports and Data Access 15

Redaction Principles Supporting Guidance – more details Guide for use of Redaction tool Examples of redaction in practice SOPs – Process descriptions Sharing Clinical Trial Reports and Data Access26 May

Data Sharing - To Consider Sharing Clinical Trial Reports and Data Access Request for Access – Frontend 26 May 2014 Review Board Data Access Requests Data to be made available System for Data Access 17

Novo Nordisk Data Sharing Process 26 May 2014 Request website Independent Review Board Data access system Data Sharing Agreement Sharing Clinical Trial Reports and Data AccessSlide no 18

Data Access Frontend 26 May 2014Sharing Clinical Trial Reports and Data Access 19

Independent Review Board 26 May 2014Sharing Clinical Trial Reports and Data Access 20

Data access solution Sharing Clinical Trial Reports and Data Access26 May Transparency System Independent Review Panel Request Web

Recoding of IDs Blanking of all verbatims Offsetting of dates Age/max age/age category considerations Grouping of sites/countries if less than … subjects Grouping of countries to continents Raw-level de-identification of rare events, socio-economic data, use of illicit drugs information De-identification 26 May 2014Sharing Clinical Trial Reports and Data Access 22

Thanks to a lot of Novo Nordisk people for sharing their slides 26 May 2014Sharing Clinical Trial Reports and Data Access 23